天智航收盘上涨2.96%，最新市净率4.53，总市值53.46亿元

Group 1 - The core viewpoint of the articles highlights Tianzhihang's position as a leading enterprise in the orthopedic surgical robot industry in China, with a focus on research, production, sales, and services of surgical navigation robots [1][2] - As of the latest quarterly report for Q3 2024, the company reported a revenue of 92.12 million yuan, reflecting a year-on-year decrease of 31.08%, and a net loss of approximately 76.17 million yuan, with a slight year-on-year decline of 5.68% [1] - The company's gross profit margin stands at 67.45%, indicating a relatively high profitability despite the decline in revenue [1] Group 2 - Tianzhihang's current stock price is 11.81 yuan, with a market capitalization of 5.346 billion yuan and a price-to-book ratio of 4.53 [1] - The company is among the top 10 members of the Chinese robotics industry and serves as a key research center for medical robotics [1] - The average price-to-earnings (PE) ratio for the industry is 47.69, while Tianzhihang's PE ratio is significantly negative at -43.42, indicating potential challenges in profitability compared to industry peers [2]